Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Anal Bioanal Chem ; 405(15): 5119-31, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23354577

RESUMO

Infections with Chlamydia pneumoniae cause several respiratory diseases, such as community-acquired pneumonia, bronchitis or sinusitis. Here, we present an integrated non-targeted metabolomics analysis applying ultra-high-resolution mass spectrometry and ultra-performance liquid chromatography mass spectrometry to determine metabolite alterations in C. pneumoniae-infected HEp-2 cells. Most important permutations are elaborated using uni- and multivariate statistical analysis, logD retention time regression and mass defect-based network analysis. Classes of metabolites showing high variations upon infection are lipids, carbohydrates and amino acids. Moreover, we observed several non-annotated compounds as predominantly abundant after infection, which are promising biomarker candidates for drug-target and diagnostic research.


Assuntos
Chlamydophila pneumoniae/fisiologia , Cromatografia Líquida/métodos , Espectrometria de Massas/métodos , Metabolômica/métodos , Biomarcadores , Técnicas de Química Analítica , Células Hep G2 , Humanos
2.
Microbes Infect ; 14(4): 311-6, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22133978

RESUMO

Pathogens that colonize or infect the human body have to face varying oxygen concentrations within different organs. Inflammation itself promotes oxygen consumption within affected tissues and creates a low oxygen environment. As a consequence, pathogens and the host immune system have to adapt to rapid changes in oxygen availability. Here we summarize recent findings on the adaptation of pathogens, host defense mechanisms and treatment strategies against intracellular pathogens in a low oxygen environment.


Assuntos
Microambiente Celular , Interações Hospedeiro-Patógeno , Consumo de Oxigênio , Imunidade Adaptativa , Anti-Infecciosos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Hipóxia Celular , Humanos , Imunidade Inata
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA